Sichuan Goldstone Asia Pharmaceutical Inc - Class A

SZSE:300434 (China)   Class A
Â¥ 8.93 (-1.33%) May 20
50.45
P/B:
1.44
Market Cap:
Â¥ 3.59B ($ 496.44M)
Enterprise V:
Â¥ 3.26B ($ 454.44M)
Volume:
1.51M
Avg Vol (2M):
4.43M
Volume:
1.51M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Sichuan Goldstone Asia Pharmaceutical Inc ( SZSE:300434 ) from 2015 to May 20 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Sichuan Goldstone Asia Pharmaceutical stock (SZSE:300434) PE ratio as of May 20 2024 is 50.45. More Details

Sichuan Goldstone Asia Pharmaceutical Inc (SZSE:300434) PE Ratio (TTM) Chart

To

Sichuan Goldstone Asia Pharmaceutical Inc (SZSE:300434) PE Ratio (TTM) Historical Data

Total 1187
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Sichuan Goldstone Asia Pharmaceutical PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-21 50.5 2024-03-12 30.7
2024-05-20 51.1 2024-03-11 29.3
2024-05-17 51.4 2024-03-08 28.6
2024-05-16 50.9 2024-03-07 28.2
2024-05-15 51.2 2024-03-06 28.8
2024-05-14 51.9 2024-03-05 29.0
2024-05-13 51.1 2024-03-04 29.9
2024-05-10 52.0 2024-03-01 29.3
2024-05-09 53.7 2024-02-29 29.2
2024-05-08 52.7 2024-02-28 28.3
2024-05-07 52.8 2024-02-27 30.2
2024-05-06 51.9 2024-02-26 29.5
2024-04-30 51.0 2024-02-23 29.3
2024-04-29 49.9 2024-02-22 28.9
2024-04-26 48.5 2024-02-21 28.4
2024-04-25 48.5 2024-02-20 28.4
2024-04-24 47.5 2024-02-19 28.2
2024-04-23 47.1 2024-02-08 27.5
2024-04-22 46.2 2024-02-07 25.9
2024-04-19 45.6 2024-02-06 26.2
2024-04-18 46.1 2024-02-05 23.7
2024-04-17 46.7 2024-02-02 26.1
2024-04-16 44.0 2024-02-01 27.4
2024-04-15 47.0 2024-01-31 27.5
2024-04-12 48.0 2024-01-30 29.2
2024-04-11 49.4 2024-01-29 30.3
2024-04-10 49.8 2024-01-26 31.6
2024-04-09 51.3 2024-01-25 31.2
2024-04-08 49.7 2024-01-24 30.0
2024-04-03 52.5 2024-01-23 29.2
2024-04-02 50.9 2024-01-22 29.0
2024-04-01 51.3 2024-01-19 31.1
2024-03-29 49.9 2024-01-18 32.0
2024-03-28 49.5 2024-01-17 32.3
2024-03-27 28.0 2024-01-16 33.4
2024-03-26 28.4 2024-01-15 33.4
2024-03-25 28.3 2024-01-12 33.4
2024-03-22 29.9 2024-01-11 33.8
2024-03-21 30.6 2024-01-10 33.1
2024-03-20 30.8 2024-01-09 33.7
2024-03-19 30.4 2024-01-08 34.0
2024-03-18 30.6 2024-01-05 34.7
2024-03-15 30.1 2024-01-04 35.4
2024-03-14 30.2 2024-01-03 35.8
2024-03-13 30.1 2024-01-02 35.6

Sichuan Goldstone Asia Pharmaceutical Inc (SZSE:300434) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Sichuan Goldstone Asia Pharmaceutical Inc is engaged in development and application of steel-reinforced plastic composite pipe technology, providing customers with steel-reinforced plastic composite pipes from pipe structure, production process to construction technology. The company is also engaged in research and development, production and sales of medicines and health products.